Chelation therapy is TACT-less

International Journal of Clinical Practice

Volumn 62, Issue 12, 2008, Pages 1821-1822

  Jackson, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; PLACEBO;

ANGINA PECTORIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CHELATION THERAPY; CLINICAL DECISION MAKING; CLINICAL TRIAL; DRUG SAFETY; EDITORIAL; HEALTH CARE POLICY; HEART FAILURE; HEART INFARCTION; HUMAN; MORTALITY; PRIORITY JOURNAL; UNITED STATES;

ANGINA PECTORIS; CHELATION THERAPY; EDETIC ACID; HUMANS;

EID: 56049096546     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01946.x     Document Type: Editorial

References (3)

1. Fraker TD Jr., Fihn SD. Writing on behalf of the 2002 Chronic Stable Angina Writing Committee. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 2007 50 : 2264 74.
2. Atwood KC, Woeckner E, Baratz RS et al. Why NIH Trial to Assess Chelation Therapy (TACT) should be abandoned. Medscape J Med 2008 10 : 115. Published online 13 May 2008 (accessed September 2008).
3. Lamas GA, Hussein SJ. EDTA chelation therapy meets evidence-based medicine. Br J Cardiol 2006 13 : 5 6.